What is she best known for?
The fields of study she is best known for:
Geraldine A. Willshaw mainly focuses on Escherichia coli, Microbiology, Plasmid, Enterobacteriaceae and Virology.
Her research integrates issues of Hybridization probe, Molecular probe, Genotype and Virulence in her study of Escherichia coli.
Her study in Microbiology is interdisciplinary in nature, drawing from both Vero cell and VTEC.
Her research in Plasmid intersects with topics in Bacteriophage and Molecular biology.
Her study in Bacteria extends to Enterobacteriaceae with its themes.
The Virology study which covers Shiga toxin that intersects with Environmental health and Transmission.
Her most cited work include:
- The emergence and spread of antibiotic resistance in food-borne bacteria. (233 citations)
- Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland (154 citations)
- Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes (151 citations)
What are the main themes of her work throughout her whole career to date?
Geraldine A. Willshaw focuses on Microbiology, Escherichia coli, Enterobacteriaceae, Plasmid and Virology.
Her studies in Microbiology integrate themes in fields like VTEC, Outbreak, Antigen, Genotype and Virulence.
Her Escherichia coli research includes elements of Hybridization probe, Molecular biology and Serotype.
In her study, Toxin, Lipopolysaccharide and Antibody is inextricably linked to Bacteria, which falls within the broad field of Enterobacteriaceae.
Her Plasmid research focuses on Bacteriophage and how it relates to Southern blot.
Her work deals with themes such as Antiserum and Enteropathogenic Escherichia coli, which intersect with Virology.
She most often published in these fields:
- Microbiology (77.89%)
- Escherichia coli (73.68%)
- Enterobacteriaceae (37.89%)
What were the highlights of her more recent work (between 2002-2016)?
- Microbiology (77.89%)
- Escherichia coli (73.68%)
- Outbreak (16.84%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Microbiology, Escherichia coli, Outbreak, Genotype and VTEC.
Her Microbiology study combines topics in areas such as Gene, Intimin and Virology.
Her studies deal with areas such as Serotype and Virulence as well as Escherichia coli.
Her Outbreak study integrates concerns from other disciplines, such as Pathogen, Biotechnology and Environmental health.
In general VTEC study, her work on Verocytotoxin often relates to the realm of National standard, European union and Validation study, thereby connecting several areas of interest.
Her Enterobacteriaceae research includes themes of Lipopolysaccharide, Saliva and Bacteria.
Between 2002 and 2016, her most popular works were:
- Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland (154 citations)
- UK epidemic Escherichia coli strains A–E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone (146 citations)
- Major Uropathogenic Escherichia coli Strain Isolated in the Northwest of England Identified by Multilocus Sequence Typing (142 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in Microbiology, Escherichia coli, Genotype, Enterobacteriaceae and Multilocus sequence typing.
Geraldine A. Willshaw interconnects Gene, VTEC and Enteropathogenic Escherichia coli in the investigation of issues within Microbiology.
The concepts of her Escherichia coli study are interwoven with issues in Molecular epidemiology and Outbreak, Virology.
Geraldine A. Willshaw has included themes like Shiga toxin, Virulence and DNA sequencing in her Molecular epidemiology study.
The Enterobacteriaceae study combines topics in areas such as clone, Lineage and Bacteria.
The study of Multilocus sequence typing is intertwined with the study of Pulsed-field gel electrophoresis in a number of ways.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
